Abstract
In order to understand the molecular mechanism of Tongguan capsule (TGC), a Traditional Chinese Medicine (TCM) for coronary heart disease (CHD), computational approaches of pharmacodynamic modeling were introduced to predict the interaction between drugs and targets about cardiovascular system. Firstly, we employed a molecular docking protocol to study the interaction of natural compounds from TGC and 13 receptors related with CHD, and screened out the potential effective components. Then the distribution of the effective components on ligand-target space was traced out, and two drug-target networks were developed to decipher the multiple components and multiple targets mechanism of TGC. Most importantly, the forecasting results of computational approaches were agreeable with some pharmacological and clinical experiments. The results showed that computational pharmacology can be an efficacious approach for the modern research of TCM in the future.
Keywords: Drug-target Network, Ligand-target Space, Pharmacodynamic(PD) Modeling, Traditional Chinese Medicine, Tongguan capsule (TGC), coronary heart disease (CHD), Traditional Chinese Medicine (TCM), Molecular Mechanism, Computational Pharmacology Methods Salvia, Gaussin distribution, Lipinski's “rule of five”, Astragalus
Letters in Drug Design & Discovery
Title: A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Volume: 8 Issue: 10
Author(s): Ding-Hong Wu, Xiao-Jie Xu, Min-Zhou Zhang and Lei Wang
Affiliation:
Keywords: Drug-target Network, Ligand-target Space, Pharmacodynamic(PD) Modeling, Traditional Chinese Medicine, Tongguan capsule (TGC), coronary heart disease (CHD), Traditional Chinese Medicine (TCM), Molecular Mechanism, Computational Pharmacology Methods Salvia, Gaussin distribution, Lipinski's “rule of five”, Astragalus
Abstract: In order to understand the molecular mechanism of Tongguan capsule (TGC), a Traditional Chinese Medicine (TCM) for coronary heart disease (CHD), computational approaches of pharmacodynamic modeling were introduced to predict the interaction between drugs and targets about cardiovascular system. Firstly, we employed a molecular docking protocol to study the interaction of natural compounds from TGC and 13 receptors related with CHD, and screened out the potential effective components. Then the distribution of the effective components on ligand-target space was traced out, and two drug-target networks were developed to decipher the multiple components and multiple targets mechanism of TGC. Most importantly, the forecasting results of computational approaches were agreeable with some pharmacological and clinical experiments. The results showed that computational pharmacology can be an efficacious approach for the modern research of TCM in the future.
Export Options
About this article
Cite this article as:
Wu Ding-Hong, Xu Xiao-Jie, Zhang Min-Zhou and Wang Lei, A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components, Letters in Drug Design & Discovery 2011; 8 (10) . https://dx.doi.org/10.2174/157018011797655331
DOI https://dx.doi.org/10.2174/157018011797655331 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Comparative Study of Non-High Density Lipoproteins Cholesterol Level and Lipid Profile in Pre-Diabetic and Diabetic Patients
CNS & Neurological Disorders - Drug Targets Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies
Current Alzheimer Research Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) The Dialogue Between Endothelial Cells and Monocytes/Macrophages in Vascular Syndromes
Current Pharmaceutical Design Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Vascular Pathology from Smoking: Look at the Microcirculation!
Current Vascular Pharmacology A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Catecholamines in Formation and Resolution of Pulmonary Oedema
Cardiovascular & Hematological Disorders-Drug Targets Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA Skeletal Muscle Derived Stem Cells for Myocardial Repair
Recent Patents on Cardiovascular Drug Discovery Pathophysiology and Therapeutics of Cardiovascular Disease in Metabolic Syndrome
Current Pharmaceutical Design Effects of Imidazolic Agonism on Blood Pressure, Sympathetic Activity, Left Ventricular Hypertrophy and Insulin Resistance
Current Hypertension Reviews Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy
Current Cardiology Reviews Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology T Cell Response in Rheumatic Fever: Crossreactivity Between Streptococcal M Protein Peptides and Heart Tissue Proteins
Current Protein & Peptide Science Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology